Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

ABSCO THERAPEUTICS, INC.

UEI: RYJ8NL66MTP3CAGE: 9WGV3

ABSCO THERAPEUTICS, INC. is a federal contractor, registered under UEI RYJ8NL66MTP3 and CAGE code 9WGV3. It has been awarded $711,500 across 2 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services and National Science Foundation.

Contact Information

Registration and classification details

Websiteabscotx.com

Address123 Main St, City, ST 12345

Registration

UEI Code

RYJ8NL66MTP3

CAGE Code

9WGV3

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

2XMF

NAICS Codes

541714Research and Development in Biotechnology (except Nanobiotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ABSCO THERAPEUTICS, INC. operates in the biomedical research and development sector, with core capabilities centered on advanced therapeutic discovery, preclinical drug development, and translational science. The company applies specialized expertise in molecular pharmacology, bioanalytical assay de...

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$406.5K57.1%

National Science Foundation$305.0K42.9%

Awards by NAICS

- Unknown NAICS$711.5K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in ABSCO THERAPEUTICS, INC.'s top NAICS codes and agencies

OHS Region 11 Training and Technical Assistance Network

Solicitation # 7571MN26C00013

The Department of the Interior’s existing contract with ICF Incorporated, LLC, numbered 140D0425C0027, has been administratively transferred to the Department of Health and Human Services under a new task order, 7571MN26C00013, effective July 1, 2026. This transfer is purely administrative and does not alter the original contract’s scope of work, deliverables, ultimate value, or period of performance. The work continues under the same terms and conditions, now managed by HHS to support the OHS Region 11 Training and Technical Assistance Network, with performance based in Reston, Virginia, and administrative oversight from Washington, DC. The contract, classified under NAICS code 541611, remains unrestricted with no set-aside requirements and is fully maintained under the original contractor’s responsibility. Point of contact for inquiries includes Carla Carter and Hamed Hassanzadeh Makou at HHS.

Department Of Health And Human Services

POSTED

about 2 months ago

DEADLINE

Portfolio Management System (OPS)

Solicitation # 7571MN26F80053

The Department of the Interior’s contract GS35F523BA/140D0422F0466, originally awarded to the Community Development Institute on May 11, 2022, for the Portfolio Management System (OPS), has been administratively transferred to the Department of Health and Human Services under the new contract number GS35F523BA/7571MN26F80053, effective June 12, 2026. This transfer does not modify any existing terms, including the ultimate contract value or the period of performance, and all scope of work, deliverables, and contractual obligations remain unchanged. The contract, identified by NAICS code 541511, is managed by HHS with the primary point of contact being Amber Harris at amber.harris@hhs.gov, and the work is performed in Madison, Wisconsin, while the contracting office is located in Washington, D.C. The contract notice was posted on June 15, 2026, and the change is purely administrative, with no impact on the contractor or the execution of the project.

Department Of Health And Human Services

POSTED

DEADLINE

NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

Solicitation # PA-27-102

This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.

Department of Health and Human Services

POSTED

DEADLINE

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

Solicitation # PA-27-100

This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.

Department of Health and Human Services

POSTED

DEADLINE

SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

Solicitation # PAR-27-098

The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.

Department of Health and Human Services

POSTED

DEADLINE

IoT Integrated Systems

Solicitation # I2

National Science Foundation

POSTED

DEADLINE

Health in Underserved Communities

Solicitation # DH3

National Science Foundation

POSTED

DEADLINE

Language-Based AI Technologies

Solicitation # AI4

National Science Foundation

POSTED

DEADLINE

Resilience and Resource Management

Solicitation # CH12

National Science Foundation

POSTED

DEADLINE

Energy Technologies

Solicitation # EN

The Energy Technologies solicitation seeks innovative proposals across a broad spectrum of energy generation, storage, and conversion systems with a focus on mobile and off-grid applications. It welcomes ideas that offer compelling advantages over existing solutions, particularly in emerging areas such as carbon conversion, disruptive improvements to conventional energy resources like natural gas extraction, and nature-inspired processes aimed at reducing carbon and resource intensity throughout the energy lifecycle. Proposals that integrate data and computational technologies with energy systems are strongly encouraged, especially where the synergy between digital innovation and energy application is central to the proposed solution. The scope spans from microscopic energy storage for wearable devices to large-scale power plant technologies, emphasizing technological scalability and sustainability. This is a small business set-aside opportunity under the SBIR/STTR mandate, restricted to organizations with fewer than 500 employees, and is classified under NAICS code 221111 for electric power generation. Managed by the National Science Foundation, the solicitation was posted on May 22, 2026, with a submission deadline of July 7, 2027. While no specific physical place of performance is required, applicants must demonstrate the potential for practical implementation and impact in the U.S. energy landscape. The initiative prioritizes breakthroughs that advance clean, efficient, and resilient energy technologies while fostering innovation within small businesses to address critical national energy challenges.

National Science Foundation

POSTED

DEADLINE

Monitoring Devices

Solicitation # BM6

National Science Foundation

POSTED

DEADLINE

Chemical and Environmental Sensing and Data

Solicitation # CT3

National Science Foundation

POSTED

DEADLINE

Assistive, Enabling and Rehabilitative technologies

Solicitation # DH1

National Science Foundation

POSTED

DEADLINE

Data Privacy and Integrity

Solicitation # CA3

National Science Foundation

POSTED

DEADLINE

Human-to-Technology Interfaces and Decentralized Applications (dApps)

Solicitation # DL12

National Science Foundation

POSTED

DEADLINE

Implantables or Procedures

Solicitation # MD2

National Science Foundation

POSTED

DEADLINE

Harvesting Complex Systems

Solicitation # AG4

National Science Foundation

POSTED

DEADLINE

Enhanced UI/UX for Immersive AR/VR/MR

Solicitation # AV2

National Science Foundation

POSTED

DEADLINE